Stewart, J., James, J., McCluggage, G., McQuaid, S., Boyle, D., Arthur, K., … Salto-Tellez, M. (2013). A strong correlation between expression of Wntless and of human epidermal growth factor receptor 2 in gastric, ovarian, and breast cancers suggests a novel-signalling pathway involving NFκB and STAT3. The Lancet, 381, S106–S106. https://doi.org/10.1016/s0140-6736(13)60546-2

Stewart, Jonathan, Jacqueline James, Glenn McCluggage, Stephen McQuaid, David Boyle, Kenneth Arthur, Paul Mullan, et al. “A strong correlation between expression of Wntless and of human epidermal growth factor receptor 2 in gastric, ovarian, and breast cancers suggests a novel-signalling pathway involving NFκB and STAT3.” The Lancet 381 (February 2013): S106–S106. https://doi.org/10.1016/s0140-6736(13)60546-2.

Stewart J, James J, McCluggage G, McQuaid S, Boyle D, Arthur K, et al. A strong correlation between expression of Wntless and of human epidermal growth factor receptor 2 in gastric, ovarian, and breast cancers suggests a novel-signalling pathway involving NFκB and STAT3. The Lancet. 2013 Feb;381:S106–S106.

Stewart, Jonathan, et al. “A strong correlation between expression of Wntless and of human epidermal growth factor receptor 2 in gastric, ovarian, and breast cancers suggests a novel-signalling pathway involving NFκB and STAT3.” The Lancet, vol. 381, Elsevier BV, Feb. 2013, pp. S106–S106. Crossref, doi:10.1016/s0140-6736(13)60546-2.

Stewart J, James J, McCluggage G, McQuaid S, Boyle D, Arthur K, Mullan P, Kidson C, McCabe N, Kennedy R, McArt D, Carson A, Yan B, Zhengdeng L, Tan P, Virshup D, Salto-Tellez M. A strong correlation between expression of Wntless and of human epidermal growth factor receptor 2 in gastric, ovarian, and breast cancers suggests a novel-signalling pathway involving NFκB and STAT3. The Lancet. Elsevier BV; 2013 Feb;381:S106–S106.